Physician profile
Ann E Narmi
NPI 1134348071
$2,645.40
in general payments reported to CMS, 2019-2025
19 companies · $766 in 2025
The $766 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $227 · 2021: $349 · 2022: $503 · 2023: $50.65 · 2024: $380 · 2025: $766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,196.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $591.45 | 2023-2025 | Symplicity G3, Aurora Ev-Icd Mri Surescan, Micra |
| Boston Scientific Corporation | $453.29 | 2021-2025 | Rotablator Rotational Atherectomy System Console Kit, Watchman Flx |
| Shockwave Medical, INC | $448.57 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $352.55 | 2019-2022 | |
| Chiesi USA, INC. | $186.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $184.13 | 2019-2025 | |
| Pfizer INC. | $68.84 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $60.84 | 2019-2021 | |
| Abbott Laboratories | $47.64 | 2022-2023 | Coroflow |
| Amgen INC. | $43.94 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $36.19 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $33.93 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $32.99 | 2020-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $29.61 | 2019-2022 | |
| Edwards Lifesciences Corporation | $21.19 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $15.85 | 2019 | |
| Scpharmaceuticals INC. | $14.00 | 2025 | |
| Medtronic Vascular, INC. | $12.93 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ann Narmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.